📦New Postal Products Notice by the Postal Regulatory Commission
The Commission is noticing a recent Postal Service filing for the Commission's consideration concerning a negotiated service agreement. This notice informs the public of the filing, invites public comment, and takes other administrative steps.
Learn More💊FDA Announces Regulatory Review Period and Patent Extension for AGAMREE
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for AGAMREE and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.
Learn More🏦Regulatory Notice on Bank Holding Companies and Mergers
The Federal Reserve System has issued a notice regarding the applications for the formation, acquisition, and merger of bank holding companies. Details on public comments and application processes are provided, inviting stakeholder input on the proposed transactions and changes in ownership structures within the banking sector.
Learn More💡NSF Seeks Input on Key Technology Focus Areas for Innovation
The U.S. National Science Foundation seeks input from academia, non-profits, philanthropy, state and local government, venture capital, the private sector and any other interested parties to inform the agency's assessment and potential update of the Key Technology Focus Areas as described in Public Law 117-167 (Research and Development, Competition, and Innovation Act.)
Learn More⚖️DOJ Guidance on Criminal Enforcement and Business Compliance
This notice describes the Department of Justice's plans to address criminally liable regulatory offenses under Executive Order 14294 on Fighting Overcriminalization in Federal Regulations.
Learn More💊FDA Determination of Regulatory Review Period for ZEVTERA Patent Extension
The Food and Drug Administration (FDA or the Agency) has determined the regulatory review period for ZEVTERA and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.
Learn More📜Discontinuation of Accelerated Examination Program for Utilities
In order to efficiently allocate examination-related resources to address pendency, and in view of the low number of requests for Accelerated Examination and the availability of a statutory program to expedite the prosecution of applications (Track One, prioritized examination), the United States Patent and Trademark Office (USPTO) is discontinuing the Accelerated Examination program for utility applications. The USPTO is also modifying the rules of practice to clarify the grounds for which a petition to make special may be granted and when a fee is required for such petition.
Learn More📈NYSE Texas Enhances Aggregated Lite Market Data Product
The SEC has published a notice regarding NYSE Texas's proposed enhancements to its Aggregated Lite market data product, including the addition of Auction Imbalance Information. This change aims to improve the quality and depth of market data available to traders and enhance transparency within the market, ultimately fostering a more competitive trading environment.
Learn More📦Notice on Priority Mail and USPS Ground Advantage Service Changes
The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.
Learn More🏢GSA Plans Rescission of Federal Management Regulation on Union Membership
GSA plans to issue a final rule rescinding the Federal Management Regulation (FMR) Case 2022-02, "Soliciting Union Memberships Among Contractors in GSA-Controlled Buildings," published on September 2, 2022.
Learn More